Get Ready to Be Breast Cancer-Savvy: Olema Oncology’s Poster Presentation at ESMO 2023 is the Talk of the Town!
Olema Oncology Announces Poster Presentation at 2023 ESMO Conference Exciting News in Cancer Research San Francisco – Olema Pharmaceuticals, Inc. has announced an upcoming poster presentation on OP-1250, their groundbreaking estrogen receptor antagonist (ER) and selective ER degrader (SERD) at the 2023 ESMO conference. This clinical-stage biopharmaceutical company, known for their focus on targeted therapies…